Anthem Biosciences (ANTHEM) Share Price falls 2.7% today
- August 28, 2026
- Posted by: Harsh Piplani
- Category: News
Anthem Biosciences Share Price is in focus after the stock declined 2.7% to Rs 899.1 on 28 August 2026. The company’s market capitalisation stands at Rs 52,027.91 crore, placing it in the Large Cap category. The move came after the stock opened at Rs 931.95, matched the day’s high at Rs 931.95, and touched a low of Rs 896.5 before closing near that range. Anthem Biosciences Share Price news today is relevant because the session shows a clear intraday retreat from the opening level, while the data supplied does not establish a company-specific catalyst.
For readers tracking Anthem Biosciences Share Price Today, the verified numbers are straightforward: current price Rs 899.1, previous close Rs 924.05, day change Rs -24.95 and day change percent -2.7%. Univest is covering the event as a stock news update built only on verified market data, without adding an unverified reason for the move. The focus now shifts to what today’s price action, valuation and sector positioning say about Anthem Biosciences Share Price as a stock in news.
Anthem Biosciences (ANTHEM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 899.1 |
| Previous Close | Rs 924.05 |
| Today's Move | -Rs 24.95 (-2.7%) |
| Open | Rs 931.95 |
| High | Rs 931.95 |
| Low | Rs 896.5 |
| Turnover | Rs 2.91 crore |
| Market Capitalisation | Rs 52,027.91 crore |
| Market Cap Category | Large Cap |
Anthem Biosciences Share Price Today moved lower in a session that started at Rs 931.95, stayed at that level as the day high, and then softened to Rs 896.5 at the low before settling at Rs 899.1. The stock therefore ended below its previous close of Rs 924.05 by Rs 24.95, which equals a 2.7% decline. The day’s range between Rs 931.95 and Rs 896.5 shows that the session had a relatively tight opening-to-high move and then a larger downward stretch into the close. That pattern is the main factual takeaway from today’s share price fall.
Turnover for the session was Rs 2.91 crore. As a Large Cap stock, Anthem Biosciences Share Price is being watched in the context of its current market capitalisation of Rs 52,027.91 crore, but the move itself should be read only as today’s price action, not as proof of any specific trigger. In Univest’s market update format, the event matters because it combines a lower close, a gap between open and close, and a fall from the prior day’s level. The next useful step is to examine how the stock’s valuation and business metrics compare with the sector backdrop.
Anthem Biosciences (ANTHEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 52,027.91 crore |
| P/E Ratio | 90.39x |
| P/B Ratio | 16.64x |
| ROE | 21.98% |
| ROCE | 29.62% |
| EPS | Rs 10.22 |
| Book Value Per Share | Rs 55.55 |
| Dividend Yield | 0.22% |
Anthem Biosciences Share Price can be understood better through its valuation and profitability profile. The stock trades at a P/E ratio of 90.39 and a P/B ratio of 16.64, both of which are well above the sector benchmark figures discussed later in this article. On profitability, ROE is 21.98% and ROCE is 29.62%, which indicate strong returns relative to the peer set and industry median. EPS stands at Rs 10.22, showing earnings attributable to each share, while book value is Rs 55.55 per share, which reflects the accounting net worth behind each share. Dividend yield is 0.22%, so the current payout history is modest relative to the current price.
The market capitalisation of Rs 52,027.91 crore places Anthem Biosciences among larger names in the Healthcare universe. That size does not by itself explain today’s share price fall, but it does provide context for why Anthem Biosciences Share Price News is followed closely by market participants tracking valuation-sensitive pharma stocks. Univest readers looking at Anthem Biosciences Stock News should note that the supplied financial ratios present a company with premium valuation and stronger return ratios than many industry benchmarks. The key question is therefore not just why the share price moved today, but how the current price sits against those fundamentals.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 90.39x |
| Benchmark Median P/E | 31.16x |
| Benchmark Average P/E | 48.05x |
| Benchmark P/E Range | 3.36x to 397.25x |
| Company P/B Ratio | 16.64x |
| Benchmark Median P/B | 2.71x |
| Benchmark Average P/B | 4.29x |
| Company ROE | 21.98% |
| Benchmark Median ROE | 11.82% |
| Benchmark Average ROE | 11.25% |
| Company ROCE | 29.62% |
| Benchmark Median ROCE | 13.71% |
| Benchmark Average ROCE | 13.74% |
| Company Market Capitalisation | Rs 52,027.91 crore |
| Benchmark Median Market Cap | Rs 664.09 crore |
| Benchmark Average Market Cap | Rs 13,883.33 crore |
Anthem Biosciences operates in Healthcare, within the Pharmaceuticals & Drugs industry, and the supplied benchmark set covers the same industry across 201 companies. That benchmark is useful because it places the stock’s P/E of 90.39 against an industry median of 31.16 and an average of 48.05. On that basis, Anthem Biosciences Share Price is linked to a valuation that is above both the median and average for the industry. Its P/B of 16.64 is also above the benchmark median of 2.71 and average of 4.29. The benchmark scope includes 200 to 201 companies depending on the metric, which gives the comparison a broad industry base.
On return ratios, Anthem Biosciences’ ROE of 21.98% stands above the industry median of 11.82% and average of 11.25%, while ROCE of 29.62% is above the median of 13.71% and average of 13.74%. This means the company’s profitability ratios are stronger than the benchmark averages, even as its valuation multiples remain well above the industry norms. In the same sector context, the market-cap median is Rs 664.09 crore and the average is Rs 13,883.33 crore, while Anthem Biosciences’ market capitalisation of Rs 52,027.91 crore is far above both figures. Univest’s sector view therefore shows a company priced more richly than the industry norm, with returns that also sit above benchmark levels.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,56,113.58 | 37.7 | 5.27 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,39,321.25 | 82.14 | 13.6 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,85,923.81 | 87.64 | 21.3 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,14,508.45 | 26.28 | 4.4 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,13,778.04 | 34.03 | 3.26 | 11.83 | 16 |
Peer comparison helps place Anthem Biosciences Share Price in a broader Healthcare context. Against Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals and Zydus Lifesciences, Anthem Biosciences has a much higher P/E than Sun Pharma’s 37.7, Divi’s 82.14, Torrent’s 87.64 and Zydus Lifesciences’ 26.28. Its P/B of 16.64 is also above Sun Pharma’s 5.27, Divi’s 13.6, Torrent’s 21.3 and Zydus Lifesciences’ 4.4 only in relation to Zydus, while still below Torrent’s figure. That makes valuation an important part of any Anthem Biosciences Stock Analysis.
On return ratios, Anthem Biosciences’ ROE of 21.98% is above Sun Pharma’s 14.85% and Divi’s 16.19%, but below Torrent’s 26.76% and above Zydus Lifesciences’ 19.69%. Its ROCE of 29.62% is higher than every peer listed here, including Sun Pharma at 19.11%, Divi’s at 21.51%, Torrent at 19.27% and Zydus Lifesciences at 21.39%. In market capitalisation terms, Anthem Biosciences’ Rs 52,027.91 crore is below Sun Pharma, Divi’s and Torrent, but above Zydus Lifesciences. For Anthem Biosciences Share Price Today, that combination of rich valuation and strong return ratios is the main peer takeaway on Univest.
Why Investors Are Watching Anthem Biosciences
- Anthem Biosciences Share Price fell 2.7% today to Rs 899.1, after closing below the previous close of Rs 924.05.
- The stock opened at Rs 931.95, hit a high of Rs 931.95 and a low of Rs 896.5 during the session.
- Turnover for the day stood at Rs 2.91 crore.
- Market capitalisation is Rs 52,027.91 crore, and the company is classified as Large Cap.
- P/E is 90.39, P/B is 16.64, ROE is 21.98%, ROCE is 29.62%, EPS is Rs 10.22 and book value is Rs 55.55.
About Anthem Biosciences
Anthem Biosciences belongs to the Healthcare sector and operates in the Pharmaceuticals & Drugs industry. The company’s market capitalisation is Rs 52,027.91 crore and it is classified as Large Cap in this article. The supplied data identifies the business at the sector and industry level, and today’s Anthem Biosciences Share Price movement is being analysed against that same framework. For Univest readers, the important company identifiers here are the sector, industry, market capitalisation and the verified market ratios, all of which help frame the stock news update without adding any unsupported business detail.
Track Anthem Biosciences Share Price on Univest
Use Anthem Biosciences (ANTHEM) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
On Univest, readers can track Anthem Biosciences Share Price Live, recent stock updates, market cap, share price fall, financial ratios, shareholding pattern, 52-week levels and company news in one place. Univest also helps compare Anthem Biosciences Stock News with sector and peer data so the day’s move can be read in context.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Anthem Biosciences Share Price fall today?
Ans. Anthem Biosciences Share Price fell 2.7% to Rs 899.1 today. The supplied data confirms the price event, but it does not establish a company-specific catalyst or reason for the decline.
What is Anthem Biosciences Share Price today?
Ans. Anthem Biosciences Share Price today is Rs 899.1. The stock was below its previous close of Rs 924.05 and traded between Rs 931.95 and Rs 896.5 during the session.
What is the market capitalisation of Anthem Biosciences?
Ans. Anthem Biosciences has a market capitalisation of Rs 52,027.91 crore. That places it in the Large Cap category and gives useful context for today’s stock news and valuation discussion.
How does Anthem Biosciences compare with sector peers?
Ans. Anthem Biosciences shows a higher P/E and P/B than the industry median and average, while its ROE and ROCE stand above benchmark levels. Compared with peers, ROCE is the strongest relative metric.
What do the valuation ratios show for Anthem Biosciences Share Price?
Ans. Anthem Biosciences Share Price is backed by a P/E of 90.39 and P/B of 16.64. EPS is Rs 10.22, book value is Rs 55.55 and dividend yield is 0.22%.
Should investors track Anthem Biosciences Share Price on Univest?
Ans. Yes. Univest tracks Anthem Biosciences Share Price Live, company news, market cap, financial ratios, shareholding pattern and 52-week levels, helping readers follow verified stock news in one place. The previous close was Rs 924.05.
